Comprehensive analysis of mammalian miRNA*species and their role in myeloid cells

Blood

Volumn 118, Issue 12, 2011, Pages 3350-3358

  Kuchenbauer, Florian ^a,b   Mah, Sarah M ^b   Heuser, Michael ^c   McPherson, Andrew ^d   Rüschmann, Jens ^b   Rouhi, Arefeh ^a   Berg, Tobias ^b   Bullinger, Lars ^a   Argiropoulos, Bob ^b   Morin, Ryan D ^d   Lai, David ^b   Starczynowski, Daniel T ^b   Karsan, Aly ^b   Eaves, Connie J ^b   Watahiki, Akira ^b   Wang, Yuzhuo ^b   Aparicio, Samuel A ^b   Ganser, Arnold ^c   Krauter, Jürgen ^c   Döhner, Hartmut ^a   Döhner, Konstanze ^a   Marra, Marco A ^d   Camargo, Fernando D ^e   Palmqvist, Lars ^f   Buske, Christian ^a   Humphries, R Keith ^b   more..

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d CANADA'S MICHAEL SMITH GENOME SCIENCES CENTRE   (Canada)

^e WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 223; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA ANALYSIS; RNA SEQUENCE;

EID: 80053176421     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-312454     Document Type: Article

References (51)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297.
2. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6(5):376-385. (Pubitemid 40637855)
3. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell. 2003;115(2):209-216. (Pubitemid 37329584)
4. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell. 2003;115(2):199-208. (Pubitemid 37329583)
5. Mah SM, Buske C, Humphries RK, Kuchenbauer F. miRNA*: a passenger stranded in RNA-induced silencing complex? Crit Rev Eukaryot Gene Expr. 2010;20(2):141-148.
6. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science. 2001; 294(5543):862-864. (Pubitemid 33032105)
7. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294(5543):858-862. (Pubitemid 33032104)
8. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T. New microRNAs from mouse and human. RNA. 2003;9(2):175-179. (Pubitemid 36206285)
9. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002; 12(9):735-739. (Pubitemid 34455427)
10. Morin RD, O'Connor MD, Griffith M, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008;18(4):610-621. (Pubitemid 351482785)
11. Kuchenbauer F, Morin RD, Argiropoulos B, et al. In-depth characterization of the microRNA transcriptome in a leukemia progression model. Genome Res. 2008;18(11):1787-1797.
12. Petriv OI, Kuchenbauer F, Delaney AD, et al. Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A. 2010;107(35):15443-15448.
13. Ruby JG, Jan C, Player C, et al. Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell. 2006;127(6):1193-1207. (Pubitemid 44894525)
14. Jagadeeswaran G, Zheng Y, Sumathipala N, et al. Deep sequencing of small RNA libraries reveals dynamic regulation of conserved and novel microRNAs and microRNA-stars during silkworm development. BMC Genomics. 2010;11:52.
15. Okamura K, Phillips MD, Tyler DM, Duan H, Chou YT, Lai EC. The regulatory activity of microRNA*species has substantial influence on microRNA and 3′ UTR evolution. Nat Struct Mol Biol. 2008;15(4):354-363. (Pubitemid 351483397)
16. Yang JS, Phillips MD, Betel D, et al. Widespread regulatory activity of vertebrate microRNA*species. RNA. 2011;17(2):312-326.
17. Ro S, Park C, Young D, Sanders KM, Yan W. Tissue-dependent paired expression of miRNAs. Nucleic Acids Res. 2007;35(17):5944-5953. (Pubitemid 47506308)
18. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, De la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105(20): 7269-7274. (Pubitemid 351754467)
19. Jazdzewski K, Liyanarachchi S, Swierniak M, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A. 2009; 106(5):1502-1505.
20. Pineault N, Buske C, Feuring-Buske M, et al. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98- HOXD13 in concert with Meis1. Blood. 2003; 101(11):4529-4538. (Pubitemid 36857824)
21. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451(7182):1125-1129. (Pubitemid 351317447)
22. Pineault N, Abramovich C, Humphries RK. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA. Leukemia. 2005;19(4):636-643. (Pubitemid 40521169)
23. Isken F, Steffen B, Merk S, et al. Identification of acute myeloid leukaemia associated microRNA expression patterns. Br J Haematol. 2008;140(2): 153-161. (Pubitemid 350265050)
24. Argiropoulos B, Palmqvist L, Yung E, et al. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3. Exp Hematol. 2008;36(7):845-849.
25. Heuser M, Beutel G, Krauter J, et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood. 2006;108(12):3898-3905. (Pubitemid 44864574)
26. Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003; 21(24):4642-4649. (Pubitemid 46594039)
27. Starczynowski DT, Kuchenbauer F, Argiropoulos B, et al. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med. 2010;16(1):49-58.
28. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83-86. (Pubitemid 38055775)
29. Fazi F, Rosa A, Fatica A, et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005;123(5):819-831. (Pubitemid 41721029)
30. Fazi F, Racanicchi S, Zardo G, et al. Epigenetic silencing of the myelopoiesis regulator microRNA- 223 by the AML1/ETO oncoprotein. Cancer Cell. 2007;12(5):457-466. (Pubitemid 350046404)
31. Shi P, Chandra J, Sun X, et al. Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells. J Cell Mol Med. 2010;14(6B):1777-1792.
32. He Y, Zhang J, Zheng J, et al. The insulin-like growth factor-1 receptor kinase inhibitor, NVP-ADW742, suppresses survival and resistance to chemotherapy in acute myeloid leukemia cells. Oncol Res. 2010;19(1):35-43.
33. Chapuis N, Tamburini J, Cornillet-Lefebvre P, et al. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Haematologica. 2010; 95(3):415-423.
34. Chapuis N, Lacombe C, Tamburini J, Bouscary D, Mayeux P. Insulin receptor A and IGF-1R in AML [letter]. Cancer Res. 2010;70(17):7010; author reply 7010.
35. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-840.
36. Li R, Pourpak A, Morris SW. Inhibition of the insulin- like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach. J Med Chem. 2009;52(16):4981-5004.
37. Regha K, Latos PA, Spahn L. The imprinted mouse Igf2r/Air cluster: a model maternal imprinting system. Cytogenet Genome Res. 2006;113(1-4):165-177.
38. Wahner Hendrickson AE, Haluska P, Schneider PA, et al. Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro. Cancer Res. 2009;69(19):7635-7643.
39. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/ miR-9*regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci. 2008;28(53):14341-14346.
40. Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB. A 3′-untranslated region (3′UTR) induces organ adhesion by regulating miR-199a*functions. PLoS One. 2009;4(2):e4527.
41. Kim S, Lee UJ, Kim MN, et al. MicroRNA miR- 199a*regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem. 2008;283(26):18158-18166.
42. Kalscheuer S, Zhang X, Zeng Y, Upadhyaya P. Differential expression of microRNAs in earlystage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1- butanone. Carcinogenesis. 2008;29(12):2394-2399.
43. Musiyenko A, Bitko V, Barik S. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates protein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med. 2008;86(3):313-322.
44. Roccaro AM, Sacco A, Chen C, et al. microRNA expression in the biology, prognosis, and therapy of Waldenstrom macroglobulinemia. Blood. 2009; 113(18):4391-4402.
45. Tsang WP, Kwok TT. The miR-18a*microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis. 2009;30(6):953-959.
46. Pass HI, Goparaju C, Ivanov S, et al. hsa-miR-29c*is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010;70(5):1916-1924.
47. Zhou H, Huang X, Cui H, et al. miR-155 and its star-form partner miR-155*cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood. 2010;116(26):5885-5894.
48. Grimson A, Srivastava M, Fahey B, et al. Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals. Nature. 2008; 455(7217):1193-1197.
49. Chatterjee S, Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature. 2009;461(7263):546-549.
50. Helgason CD, Damen JE, Rosten P, et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 1998;12(11):1610-1620. (Pubitemid 28299513)
51. Shimon I, Shpilberg O. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk Res. 1995;19(4):233-240.